Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03190668 · ClinicalTrials.gov registry record · Phase 4
Skeletal Muscle and Adipose Tissue Study
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT03190668 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 12 participants.
The verdict
NCT03190668, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the current standard of care for prophylactic Cefazolin administered every 3 hours intravenously with continuous infusion of Cefazolin during pediatric spinal surgery.
Interventions
- DRUG Bolus dose of Cefazolin
- DRUG Continuous Cefazolin drip
- DEVICE Paraspinal muscle microdialysis catheters
- DEVICE Subcutaneous microdialysis catheters
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-05-29 |
| Est. Completion | 2022-06-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03190668
The ClinicalTrials.gov registry entry for NCT03190668 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Bolus dose of Cefazolin is the first listed.
NCT03190668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03190668 about?
NCT03190668 is a clinical study titled "Skeletal Muscle and Adipose Tissue Study". The purpose of this research study is to compare the current standard of care for prophylactic Cefazolin administered every 3 hours intravenously with continuous infusion of Cefazolin during pediatric spinal surgery.
What is the current status of trial NCT03190668?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2018-05-29. Estimated completion is 2022-06-23.
What interventions are being tested in trial NCT03190668?
The interventions under investigation include: Bolus dose of Cefazolin (DRUG), Continuous Cefazolin drip (DRUG), Paraspinal muscle microdialysis catheters (DEVICE), Subcutaneous microdialysis catheters (DEVICE).
Who is sponsoring clinical trial NCT03190668?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.